Company / R&D per Share
KESTRA MEDICAL TECHNOLOGIES, LTD. R&D per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.64
FY2024
5-year range
$0.64 / $0.78
FY2023-FY2024
Trend
-18.3%
vs FY2023
Sector context
#84 of 108
Health Care
What the data says
KESTRA MEDICAL TECHNOLOGIES, LTD.'s r&d per share of $0.64 is lower than 78% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
0.64 in FY2024.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 108This company $0.64 Sector average $2.07
▼
-69.2% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 18.3% year-over-year.
- Ranks #84 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.01 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.64 | -18.3% |
| FY2023 | $0.78 | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026